Transdermal Drug Delivery
Efficient iontophoretic timolol transport achieved in vitro
Published in Heart Disease Weekly, March 27th, 2005
Scientists in the Netherlands conducted a study "to determine the key factors that control timolol electrotransport," and "to investigate the possibility of delivering therapeutic doses of this drug" through iontophoresis.
"The effect of different factors affecting the iontophoretic transport of timolol was investigated," explained D.G. Fatouros and coauthors at the Leiden/Amsterdam Center for Drug Research. "Anodal iontophoretic transport of timolol was measured as a function of its concentration, temperature, pH, and ionic strength."
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Heart Disease Weekly
Source: Heart Disease Weekly (2005-03-27)
More Articles from Heart Disease Weekly
- Heart Failure
CPU 86017 improved cardiac performance in acute and chronic heart failure - Heart Failure
Candesartan is an important treatment in chronic heart failure - Heart Failure
Focus on symptomatic relief leads to underuse of ACE inhibitors, beta-blockers - Ischemia/Reperfusion
Study investigated effects of sildenatil citrate on ischemia reperfusion injury - Myocarditis
IFN-gamma (KO) mice have greater progression to dilated cardiomyopathy and HF - ACE Inhibitors
Cardioprotection of zofenopril is greater than non-sulphydryl ACE inhibitors - More from this issue of Heart Disease Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
